메뉴 건너뛰기




Volumn 159, Issue 2, 2008, Pages 87-89

Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure

Author keywords

Biguanides; Lactic acidosis; Metformin; Type 2 diabetes mellitus

Indexed keywords

BICARBONATE; INFUSION FLUID; METFORMIN;

EID: 43549108771     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (21)
  • 2
    • 27744565691 scopus 로고    scopus 로고
    • Metformin revisited: Re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents
    • Goodarzi MO, Bryer-Ash M. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes Obes Metab 2005; 7(6):654-65
    • (2005) Diabetes Obes Metab , vol.7 , Issue.6 , pp. 654-665
    • Goodarzi, M.O.1    Bryer-Ash, M.2
  • 3
    • 13644263258 scopus 로고    scopus 로고
    • Oral antidiabetic agents: Current role in type 2 diabetes mellitus
    • Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005; 65(3):385-411
    • (2005) Drugs , vol.65 , Issue.3 , pp. 385-411
    • Krentz, A.J.1    Bailey, C.J.2
  • 4
    • 0035140640 scopus 로고    scopus 로고
    • Lactic acidosis update for critical care clinicians
    • Luft FC. Lactic acidosis update for critical care clinicians. J Am Soc Nephrol 2001; 12(suppl 17):S15-9
    • (2001) J Am Soc Nephrol , vol.12 , Issue.SUPPL. 17
    • Luft, F.C.1
  • 5
    • 27844555543 scopus 로고    scopus 로고
    • Lactic acidosis associated with metformin use in treatment of type 2 diabetes mellitus
    • De Palo VA, Mailer K, Yoburn D, et al. Lactic acidosis associated with metformin use in treatment of type 2 diabetes mellitus. Geriatrics 2005; 60(11):36-41
    • (2005) Geriatrics , vol.60 , Issue.11 , pp. 36-41
    • De Palo, V.A.1    Mailer, K.2    Yoburn, D.3
  • 6
    • 33646857242 scopus 로고    scopus 로고
    • Metformin-associated lactic acidosis treated with continous renal replacement therapy
    • Alivanis P, Giannikouris I, Paliuras C, et al. Metformin-associated lactic acidosis treated with continous renal replacement therapy. Clin Ther 2006; 28(3):396-400
    • (2006) Clin Ther , vol.28 , Issue.3 , pp. 396-400
    • Alivanis, P.1    Giannikouris, I.2    Paliuras, C.3
  • 7
    • 3042798575 scopus 로고    scopus 로고
    • The phantom of lactic acidosis due to metformin in patients with diabetes
    • Misbin RI. The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care 2004; 27(7):1791-3
    • (2004) Diabetes Care , vol.27 , Issue.7 , pp. 1791-1793
    • Misbin, R.I.1
  • 8
    • 0344420380 scopus 로고    scopus 로고
    • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: Systematic review and meta-analysis
    • Salpeter SR, Greyber E, Pasternak GA, et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2003; 163(21):2594-602
    • (2003) Arch Intern Med , vol.163 , Issue.21 , pp. 2594-2602
    • Salpeter, S.R.1    Greyber, E.2    Pasternak, G.A.3
  • 9
    • 0027054576 scopus 로고
    • Biguanide related lactic acidosis: Incidence and risk factors
    • Aguilar C, Reza A, Garcia JE, et al. Biguanide related lactic acidosis: incidence and risk factors. Arch Med Res 1992; 23:19-24
    • (1992) Arch Med Res , vol.23 , pp. 19-24
    • Aguilar, C.1    Reza, A.2    Garcia, J.E.3
  • 10
    • 0024465303 scopus 로고
    • Oral hypoglycemic agents
    • Gerich JE. Oral hypoglycemic agents. N Engl J Med 1989; 321(18):1231-45
    • (1989) N Engl J Med , vol.321 , Issue.18 , pp. 1231-1245
    • Gerich, J.E.1
  • 11
    • 0032185972 scopus 로고    scopus 로고
    • Metformin and lactic acidosis: Guilt by association
    • Stacpoole PW. Metformin and lactic acidosis: guilt by association. Diabetes Care 1998; 21:1587-8
    • (1998) Diabetes Care , vol.21 , pp. 1587-1588
    • Stacpoole, P.W.1
  • 12
    • 0019799332 scopus 로고
    • A method for estimating the probability of adverse drug reactions
    • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2):239-45
    • (1981) Clin Pharmacol Ther , vol.30 , Issue.2 , pp. 239-245
    • Naranjo, C.A.1    Busto, U.2    Sellers, E.M.3
  • 13
    • 0029933886 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of metformin
    • Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 1996; 30:359-71
    • (1996) Clin Pharmacokinet , vol.30 , pp. 359-371
    • Scheen, A.J.1
  • 14
    • 0032985166 scopus 로고    scopus 로고
    • A risk-benefit assessment of metformin in type 2 diabetes mellitus
    • Howlett HC, Bailey CJ. A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf 1999; 20:489-503
    • (1999) Drug Saf , vol.20 , pp. 489-503
    • Howlett, H.C.1    Bailey, C.J.2
  • 15
    • 2342441532 scopus 로고    scopus 로고
    • Metformin induced acute pancreatitis precipitated by renal failure
    • Mallick S. Metformin induced acute pancreatitis precipitated by renal failure. Postgrad Med J 2004; 80(942):239-40
    • (2004) Postgrad Med J , vol.80 , Issue.942 , pp. 239-240
    • Mallick, S.1
  • 16
    • 33746327485 scopus 로고    scopus 로고
    • Metformin-induced pancreatitis: A possible adverse drug effect during acute renal failure
    • Fimognari FL, Corsonello A, Pastorell R, et al. Metformin-induced pancreatitis: a possible adverse drug effect during acute renal failure. Diabetes Care 2006; 29(5):1183
    • (2006) Diabetes Care , vol.29 , Issue.5 , pp. 1183
    • Fimognari, F.L.1    Corsonello, A.2    Pastorell, R.3
  • 17
    • 0033761206 scopus 로고    scopus 로고
    • Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: Incidence and correlation with biochemical abnormalities
    • Yadav D, Nair S, Norkus EP, et al. Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol 2000; 95(11):3123-8
    • (2000) Am J Gastroenterol , vol.95 , Issue.11 , pp. 3123-3128
    • Yadav, D.1    Nair, S.2    Norkus, E.P.3
  • 18
    • 33747087884 scopus 로고    scopus 로고
    • Metabolic acidosis: Pathophysiology, diagnosis and management
    • Adrogue HJ. Metabolic acidosis: pathophysiology, diagnosis and management. J Nephrol 2006; 19 Suppl 9:S62-9
    • (2006) J Nephrol , vol.19 , Issue.SUPPL. 9
    • Adrogue, H.J.1
  • 19
    • 33645335759 scopus 로고    scopus 로고
    • Severe lactic acidosis treated with prolonged hemodialysis: Recovery after massive overdoses of metformin
    • Guo PY, Storsley LJ, Finkle SN. Severe lactic acidosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin. Semin Dial 2006; 19(1):80-3
    • (2006) Semin Dial , vol.19 , Issue.1 , pp. 80-83
    • Guo, P.Y.1    Storsley, L.J.2    Finkle, S.N.3
  • 20
    • 0031829840 scopus 로고    scopus 로고
    • The management of metformin overdose
    • Teale KF, Devine A, Stewart H, et al. The management of metformin overdose. Anaesthesia 1998; 53:698-701
    • (1998) Anaesthesia , vol.53 , pp. 698-701
    • Teale, K.F.1    Devine, A.2    Stewart, H.3
  • 21
    • 0032917623 scopus 로고    scopus 로고
    • Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations
    • Lalau JD, Race JM. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999; 20:377-84
    • (1999) Drug Saf , vol.20 , pp. 377-384
    • Lalau, J.D.1    Race, J.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.